• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验性胆囊收缩素四肽诱导惊恐后谷氨酸浓度的急性变化——健康受试者的 3T-MRS 研究。

Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjects.

机构信息

Mood and Anxiety Disorders Research Unit, Department of Psychiatry and Psychotherapy, University of Muenster, Muenster, Germany.

出版信息

Neuropsychopharmacology. 2013 Aug;38(9):1648-54. doi: 10.1038/npp.2013.61. Epub 2013 Mar 5.

DOI:10.1038/npp.2013.61
PMID:23463151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3717541/
Abstract

According to preclinical studies, glutamate has been implicated in the pathogenesis of anxiety. In order to elucidate the role of glutamate in anxiety and panic in humans, brain glutamate+glutamine (Glx) levels were measured during cholecystokinin-tetrapeptide (CCK-4)-induced panic using magnetic resonance spectroscopy (MRS). Eighteen healthy subjects underwent a CCK-4 challenge. MR spectra were obtained from the anterior cingulate cortex (ACC) using a single voxel point-resolved spectroscopy method and analyzed using LCModel. A combined fitting of Glx was performed. Panic was assessed using the Acute Panic Inventory (API) and Panic Symptom Scale (PSS) scores. Moreover, hypothalamic-pituitary-adrenal axis stimulation was monitored throughout the challenge. There was a significant panic response following CCK-4 as revealed by a marked increase in both the panic scores (API: F(1,17)=149.41; p<0.0001; PSS: F(1,17)=88.03; p<0.0001) and heart rate (HR: F(1,17)=72.79; p<0.0001). MRS measures showed a significant increase of brain Glx/creatine (Glx/Cr) levels peaking at 2-10 min after challenge (F(1,17)=15.94; p=0.001). There was also a significant increase in CCK-4-related cortisol release (F(6,11)=8.68; p=0.002). Finally, significant positive correlations were found between baseline Glx/Cr and both APImax (r=0.598; p=0.009) and maximum heart rate (HR(max)) during challenge (r=0.519; p=0.027). Our results suggest that CCK-4-induced panic is accompanied by a significant glutamate increase in the bilateral ACC. The results add to the hypothesis of a disturbance of the inhibitory-excitatory equilibrium and suggest that apart from static alterations rapid and dynamic neurochemical changes might also be relevant for the neural control of panic attacks.

摘要

根据临床前研究,谷氨酸已被牵连到焦虑症的发病机制中。为了阐明谷氨酸在人类焦虑和恐慌中的作用,使用磁共振波谱(MRS)测量胆囊收缩素-四肽(CCK-4)诱导的恐慌期间的脑谷氨酸+谷氨酰胺(Glx)水平。18 名健康受试者接受了 CCK-4 挑战。使用单体点分辨光谱法从前扣带皮层(ACC)获得 MR 光谱,并使用 LCModel 进行分析。进行了 Glx 的联合拟合。使用急性恐慌量表(API)和恐慌症状量表(PSS)评分评估恐慌。此外,在整个挑战过程中监测了下丘脑-垂体-肾上腺轴的刺激。CCK-4 后出现明显的恐慌反应,这表现为恐慌评分(API:F(1,17)=149.41;p<0.0001;PSS:F(1,17)=88.03;p<0.0001)和心率(HR:F(1,17)=72.79;p<0.0001)明显增加。MRS 测量显示,脑 Glx/肌酸(Glx/Cr)水平在挑战后 2-10 分钟显着增加(F(1,17)=15.94;p=0.001)。CCK-4 相关皮质醇释放也显着增加(F(6,11)=8.68;p=0.002)。最后,发现基线 Glx/Cr 与 API 最大值(r=0.598;p=0.009)和挑战期间最大心率(HR(max))之间存在显著正相关(r=0.519;p=0.027)。我们的结果表明,CCK-4 诱导的恐慌伴随着双侧 ACC 中谷氨酸的显着增加。这些结果增加了抑制-兴奋平衡紊乱的假说,并表明除了静态改变外,快速和动态神经化学变化也可能与恐慌发作的神经控制有关。

相似文献

1
Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjects.实验性胆囊收缩素四肽诱导惊恐后谷氨酸浓度的急性变化——健康受试者的 3T-MRS 研究。
Neuropsychopharmacology. 2013 Aug;38(9):1648-54. doi: 10.1038/npp.2013.61. Epub 2013 Mar 5.
2
Neuropeptide S receptor gene variation modulates anterior cingulate cortex Glx levels during CCK-4 induced panic.神经肽S受体基因变异在胆囊收缩素-4诱发惊恐期间调节前扣带回皮质的谷氨酸盐/谷氨酰胺(Glx)水平。
Eur Neuropsychopharmacol. 2015 Oct;25(10):1677-82. doi: 10.1016/j.euroneuro.2015.07.011. Epub 2015 Jul 20.
3
Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.阿普唑仑对胆囊收缩素四肽诱发的惊恐及下丘脑-垂体-肾上腺轴活性的影响:一项安慰剂对照研究。
Neuropsychopharmacology. 2003 May;28(5):979-84. doi: 10.1038/sj.npp.1300131. Epub 2003 Mar 26.
4
Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4).重复经颅磁刺激(rTMS)对胆囊收缩素四肽(CCK-4)诱发的惊恐发作的影响。
Int J Neuropsychopharmacol. 2007 Apr;10(2):285-9. doi: 10.1017/S146114570600695X. Epub 2006 Jul 3.
5
Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.促肾上腺皮质激素(ACTH)浓度升高与惊恐障碍患者中胆囊收缩素四肽诱导的惊恐发作有关。
Neuropsychopharmacology. 2000 Mar;22(3):251-6. doi: 10.1016/S0893-133X(99)00115-3.
6
Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.甲地孕酮可减弱对CCK - 4诱导的惊恐发作的激素反应。
Depress Anxiety. 2006;23(3):139-44. doi: 10.1002/da.20147.
7
Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone.地塞米松和氢化可的松对 CCK-4 诱发恐慌的差异作用。
World J Biol Psychiatry. 2012 Oct;13(7):526-34. doi: 10.3109/15622975.2011.604351. Epub 2011 Nov 23.
8
Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex.小儿双相情感障碍中的躁狂、谷氨酸/谷氨酰胺与利培酮:前扣带回皮质的质子磁共振波谱研究
J Affect Disord. 2007 Apr;99(1-3):19-25. doi: 10.1016/j.jad.2006.08.023. Epub 2006 Sep 26.
9
Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study.在一项概念验证研究中,对健康志愿者群体中作为激发范式的CCK-4模型进行评估。
Psychopharmacology (Berl). 2007 Jul;192(4):479-87. doi: 10.1007/s00213-007-0738-7. Epub 2007 Feb 23.
10
Copeptin - A potential endocrine surrogate marker of CCK-4-induced panic symptoms?copeptin——一种CCK-4诱导的惊恐症状潜在的内分泌替代标志物?
Psychoneuroendocrinology. 2017 Feb;76:14-18. doi: 10.1016/j.psyneuen.2016.11.006. Epub 2016 Nov 8.

引用本文的文献

1
The Role of Glutamate and Blood-Brain Barrier Disruption as a Mechanistic Link between Epilepsy and Depression.谷氨酸和血脑屏障破坏在癫痫和抑郁之间的机制联系中的作用。
Cells. 2024 Jul 21;13(14):1228. doi: 10.3390/cells13141228.
2
Neurochemical and genetic factors in panic disorder: a systematic review.惊恐障碍的神经化学和遗传因素:系统评价。
Transl Psychiatry. 2024 Jul 18;14(1):294. doi: 10.1038/s41398-024-02966-0.
3
Cholecystokinin neurotransmission in the central nervous system: Insights into its role in health and disease.中枢神经系统中的胆囊收缩素神经传递:对其在健康与疾病中作用的见解。
Biofactors. 2024 Nov-Dec;50(6):1060-1075. doi: 10.1002/biof.2081. Epub 2024 May 22.
4
Glutamate Neurotoxicity and Destruction of the Blood-Brain Barrier: Key Pathways for the Development of Neuropsychiatric Consequences of TBI and Their Potential Treatment Strategies.谷氨酸神经毒性和血脑屏障破坏:TBI 所致神经精神后果发展的关键途径及其潜在治疗策略。
Int J Mol Sci. 2022 Aug 25;23(17):9628. doi: 10.3390/ijms23179628.
5
Anxiety, Mental Stress, and Sudden Cardiac Arrest: Epidemiology, Possible Mechanisms and Future Research.焦虑、精神压力与心源性猝死:流行病学、可能机制及未来研究
Front Psychiatry. 2022 Feb 3;12:813518. doi: 10.3389/fpsyt.2021.813518. eCollection 2021.
6
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications.辅助和教唆快感缺失:炎症对大脑的影响及药理学意义。
Pharmacol Rev. 2021 Jul;73(3):1084-1117. doi: 10.1124/pharmrev.120.000043.
7
Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A "Dimmer-Switch" Hypothesis.胆囊收缩素介导的焦虑和精神分裂症的神经调节:“调光开关”假说。
Curr Neuropharmacol. 2021;19(7):925-938. doi: 10.2174/1570159X18666201113145143.
8
Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression: A Randomized Clinical Trial.评估氯胺酮剂量与成人重性抑郁磁共谱 Glx 和 GABA 反应的关系:一项随机临床试验。
JAMA Netw Open. 2020 Aug 3;3(8):e2013211. doi: 10.1001/jamanetworkopen.2020.13211.
9
Gene-environment interaction: New insights into perceived parenting and social anxiety among adolescents.基因-环境交互作用:青少年感知到的教养方式和社交焦虑的新见解。
Eur Psychiatry. 2020 Jun 8;63(1):e64. doi: 10.1192/j.eurpsy.2020.62.
10
Are working memory and glutamate concentrations involved in early-life stress and severity of psychosis?工作记忆和谷氨酸浓度是否与生命早期压力和精神病严重程度有关?
Brain Behav. 2020 Jun;10(6):e01616. doi: 10.1002/brb3.1616. Epub 2020 May 9.

本文引用的文献

1
Benzodiazepines counteract rostral anterior cingulate cortex activation induced by cholecystokinin-tetrapeptide in humans.苯二氮䓬类药物可拮抗人类胆囊收缩素-四肽诱导的前扣带回皮质激活。
Biol Psychiatry. 2013 Feb 15;73(4):337-44. doi: 10.1016/j.biopsych.2012.09.004. Epub 2012 Oct 8.
2
Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders.转位蛋白(18kDa)(TSPO)作为焦虑和神经紊乱疾病的治疗靶点。
Eur Arch Psychiatry Clin Neurosci. 2012 Nov;262 Suppl 2:S107-12. doi: 10.1007/s00406-012-0352-5. Epub 2012 Aug 26.
3
Neuronal network of panic disorder: the role of the neuropeptide cholecystokinin.惊恐障碍的神经网络:神经肽胆囊收缩素的作用。
Depress Anxiety. 2012 Sep;29(9):762-74. doi: 10.1002/da.21919. Epub 2012 May 2.
4
Vigorous exercise increases brain lactate and Glx (glutamate+glutamine): a dynamic 1H-MRS study.剧烈运动增加脑内乳酸和 Glx(谷氨酸+谷氨酰胺):一项动态 1H-MRS 研究。
Neuroimage. 2011 Aug 15;57(4):1324-30. doi: 10.1016/j.neuroimage.2011.05.048. Epub 2011 May 27.
5
Anterior cingulate proton spectroscopy glutamate levels differ as a function of smoking cessation outcome.前扣带质子波谱谷氨酸水平随戒烟结果而变化。
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1709-13. doi: 10.1016/j.pnpbp.2011.05.006. Epub 2011 May 15.
6
New perspectives in glutamate and anxiety.谷氨酸与焦虑的新视角。
Pharmacol Biochem Behav. 2012 Feb;100(4):752-74. doi: 10.1016/j.pbb.2011.04.010. Epub 2011 Apr 30.
7
The use of cognitive enhancers in animal models of fear extinction.在恐惧消退的动物模型中使用认知增强剂。
Pharmacol Biochem Behav. 2011 Aug;99(2):217-28. doi: 10.1016/j.pbb.2011.01.009. Epub 2011 Jan 20.
8
Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders.转位蛋白(18kDa)(TSPO)作为神经和精神疾病的治疗靶点。
Nat Rev Drug Discov. 2010 Dec;9(12):971-88. doi: 10.1038/nrd3295.
9
The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology.焦虑症的神经生物学:脑成像、遗传学与心理神经内分泌学。
Clin Lab Med. 2010 Dec;30(4):865-91. doi: 10.1016/j.cll.2010.07.006.
10
Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists.代谢型谷氨酸受体激动剂和拮抗剂的潜在精神科应用。
CNS Drugs. 2010 Aug;24(8):669-93. doi: 10.2165/11533230-000000000-00000.